Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?

We describe 12 patients with Parkinson's disease and pathologic gambling. This association has apparently never been reported. The patients were selected from a Parkinson's disease unit of 250 patients. They met Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria for pathologic gambling. All patients underwent a neurologic, psychiatric, and psychologic examination, specifically noting the presence or absence of psychopathology in the spectrum of impulse control disorder and the nature of the gambling. Ten patients started gambling after the onset of Parkinson's disease and treatment with levodopa. The pathologic behavior was exclusively present or was markedly increased in “on” periods in 11 patients. All patients had motor fluctuations at the time of the study. Slot machines were the preferred source of gambling for 10 patients, similar to the Spanish gambling population. That the gambling behavior appears more often in the “on” periods of motor fluctuations and that it begins after the onset of Parkinson's disease in most patients and worsens with levodopa therapy suggest that it could be related to the dopaminergic tone in patients with Parkinson's disease and motor fluctuations (that is, it could represent a behavioral manifestation of pharmacologic treatment).

[1]  D. Comings,et al.  A study of the dopamine D2 receptor gene in pathological gambling. , 1996, Pharmacogenetics.

[2]  E. Hollander,et al.  Serotonergic and Noradrenergic Function in Pathological Gambling , 1998, CNS Spectrums.

[3]  J. Fernández-Piqueras,et al.  Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. , 1997, Pharmacogenetics.

[4]  O. Hornykiewicz,et al.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy. , 1975, The Journal of pharmacology and experimental therapeutics.

[5]  D. Comings,et al.  Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB) , 1997, Molecular Psychiatry.

[6]  E. Hollander,et al.  Low platelet monoamine oxidase activity in pathological gambling , 1994, Acta psychiatrica Scandinavica.

[7]  E. Becoña Pathological Gambling in Spanish Children and Adolescents: An Emerging Problem , 1997, Psychological reports.

[8]  S. Nakajima Subtypes of dopamine receptors involved in the mechanism of reinforcement , 1989, Neuroscience & Biobehavioral Reviews.

[9]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[10]  F. Jiménez-Jiménez,et al.  Risk‐factors for Parkinson's disease: case‐control study in the province of Cáceres, Spain , 1994, Acta neurologica Scandinavica.

[11]  M. Linnoila,et al.  Pathological gambling. A psychobiological study. , 1988, Archives of general psychiatry.

[12]  D. Mateo,et al.  Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case‐control study , 1992, Movement disorders : official journal of the Movement Disorder Society.

[13]  P. Södersten,et al.  Altered dopamine function in pathological gambling , 1997, Psychological Medicine.

[14]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[15]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[16]  P. Keck,et al.  The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. , 1992, The American journal of psychiatry.

[17]  D. Comings,et al.  Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors , 1997, Molecular Psychiatry.

[18]  Ting-kai Li,et al.  Effects of D1 and D2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. , 1993, Alcohol.

[19]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.